Published on: 6 June 2017
Published on: 19 May 2017
4th Ottawa International Conference on Neuromuscular Disease & Biology
September 7-9, 2017, Ottawa, Canada
Highlighting Recent Advances in Basic, Translational & Clinical Neuromuscular Disease Research (Neuromuscular and Stem Cell Biology, Muscle Atrophy, ALS, SMA, Neuropathies, Myasthenic Syndromes, Muscular & Myotonic Dystrophies, Myopathies)
Understanding how muscles work is important, but dissecting muscle fibers from humans is difficult, could an alternative option be myotubes?
Research published in Skeletal Muscle investigates this, Jennifer Levy explains more.
Tackling ischemia to treat DMD: In this publication, Nelson et al proposed to use PDE5 inhibitors to treat DMD.
Aims and scope
Skeletal Muscle is a peer-reviewed, open access, online journal that publishes articles investigating molecular mechanisms underlying the biology of skeletal muscle. A wide range of skeletal muscle biology is included: development, metabolism, the regulation of mass and function, aging, degeneration, dystrophy and regeneration. The emphasis is on understanding adult skeletal muscle, its maintenance, and its interactions with non-muscle cell types and regulatory modulators.
David Glass, co-Editor-in-Chief
"The goal of the journal is to understand how the skeletal muscle relevant cellular systems work, so that one might be able to improve human health and combat disease.”